Promore Pharma AB 

SEK0.11
2
-SEK12.33-99.12% Tuesday 16:21

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

17MayExpected
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-0.22
-0.18
-0.14
-0.09
Expected EPS
N/A
Actual EPS
-0.138

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-26.62MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PROMO.ST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which has completed Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is headquartered in Solna, Sweden.
Show more...
CEO
Dr. Jonas Ekblom Ph.D.
Employees
1
Country
SE
ISIN
SE0009947740
WKN
000A2DTCZ

Listings

0 Comments

Share your thoughts

FAQ

What is Promore Pharma AB stock price today?
The current price of PROMO.ST is SEK0.11 SEK — it has decreased by -99.12% in the past 24 hours. Watch Promore Pharma AB stock price performance more closely on the chart.
What is Promore Pharma AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Promore Pharma AB stocks are traded under the ticker PROMO.ST.
What were Promore Pharma AB earnings last quarter?
PROMO.ST earnings for the last quarter are -0.14 SEK per share, whereas the estimation was N/A SEK resulting in a N/A surprise. The estimated earnings for the next quarter are N/A SEK per share.
What is Promore Pharma AB revenue for the last year?
Promore Pharma AB revenue for the last year amounts to 0 SEK.
What is Promore Pharma AB net income for the last year?
PROMO.ST net income for the last year is -26.62M SEK.
How many employees does Promore Pharma AB have?
As of April 03, 2026, the company has 1 employees.
In which sector is Promore Pharma AB located?
Promore Pharma AB operates in the Healthcare sector.
When did Promore Pharma AB complete a stock split?
Promore Pharma AB has not had any recent stock splits.
Where is Promore Pharma AB headquartered?
Promore Pharma AB is headquartered in Solna, SE.